Investment Summary |
|
|---|---|
| Date | 2021-03-22 |
| Target | XyloCor Therapeutics |
| Sector | Leisure |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 35 of 47 |
| Sector: Leisure M&A | 1 of 1 |
| Type: Venture M&A Deals | 29 of 39 |
| State: Pennsylvania M&A | 1 of 1 |
| Country: United States M&A | 7 of 11 |
| Year: 2021 M&A | 3 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-25 |
Simplify
Sunnyvale, California, United States Simplify is a medical device company focused on cervical spinal disc arthroplasty, using innovative, MRI-compatible materials designed to optimize diagnostic imaging and decrease the need for ionizing radiation. Simplify was founded in 2013 and is based in Sunnyvale, California. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-07 |
Innovative Molecules
Munich, Germany Innovative Molecules is a drug development company focused on developing next-generation treatments for Herpes simplex-induced diseases. Innovative Molecules is based in Munich, Germany. |
Buy | - |
